| SORCS3 | |
|---|---|
| Gene | [SORCS3](/genes/sorcs3) |
| UniProt ID | [Q9UPQ6](https://www.uniprot.org/uniprot/Q9UPQ6) |
| Molecular Weight | 120 kDa |
| Subcellular Localization | Plasma membrane, endosomes |
| Protein Family | VPS10P domain receptor family |
| Brain Expression | High in [hippocampus](/brain-regions/hippocampus), [cortex](/brain-regions/cortex) |
SORCS3 (Sortilin-Related VPS10 Domain Containing Receptor 3) is a neuronal transmembrane receptor that plays critical roles in synaptic function, protein trafficking, and intracellular signaling in the central nervous system. As a member of the VPS10P domain receptor family, SORCS3 shares structural and functional similarities with other sortilin-related receptors including SORCS1 and SORCS2, all of which have been implicated in neurodegenerative diseases [1].
SORCS3 is a type I transmembrane receptor with several distinct structural domains:
The VPS10P domain adopts a 10-bladed beta-propeller structure that creates a large ligand-binding pocket capable of recognizing diverse cargo proteins [2].
SORCS3 is predominantly expressed in neurons of the hippocampus and cerebral cortex, regions critical for learning and memory. The receptor localizes to both presynaptic terminals and postsynaptic densities, where it participates in:
As a sorting receptor, SORCS3 directs proteins between different cellular compartments:
SORCS3 interacts with various neurotrophic factors and their precursors, modulating neuronal survival and differentiation pathways [^3].
Genome-wide association studies (GWAS) have identified SORCS3 variants as significant risk factors for Alzheimer's disease. Multiple single nucleotide polymorphisms (SNPs) in the SORCS3 gene locus have been associated with:
SORCS3 deficiency contributes to synaptic impairment through multiple mechanisms:
SORCS3 influences amyloid precursor protein (APP) processing and amyloid-beta metabolism. Studies show that:
Evidence suggests SORCS3 may be involved in tau phosphorylation and aggregation:
SORCS3 represents a potential therapeutic target for AD:
While primarily studied in AD, SORCS3 variants have also been associated with Parkinson's disease risk, suggesting common mechanistic pathways in protein homeostasis.
SORCS3 has been linked to:
Key protein interactions include:
SORCS3 is a critical neuronal receptor that links synaptic function with protein trafficking pathways. Its role in AD pathogenesis makes it an important target for understanding disease mechanisms and developing therapeutic interventions. The receptor's involvement in multiple neurodegenerative and psychiatric disorders highlights its broader importance in nervous system function.